Kraig Biocraft Laboratories Income Statement (2010-2025) | KBLB

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)
Cost of Revenue (Quarter)
Gross Profit (Quarter)
Operating items
Amortization - Intangibles (Quarter)
Research & Development (Quarter)	0.09M	0.04M	0.04M	0.03M	0.03M	0.05M	0.06M	0.04M	0.07M	0.06M	0.04M	0.07M	0.03M	0.05M	0.02M	0.06M	0.02M	0.06M	0.01M	0.07M
Selling, General & Administrative (Quarter)	0.31M	0.37M	0.64M	0.18M	0.21M	0.21M	0.21M	0.19M	0.21M	0.22M	0.22M	0.80M	0.16M	1.10M	0.21M	0.28M	0.31M	0.34M	1.20M	0.11M
Other Operating Expenses (Quarter)	0.27M	0.29M	0.20M	0.31M	0.31M	0.27M	0.26M	0.28M	0.21M	0.20M	0.20M	0.32M	0.25M	0.34M	0.03M	0.38M	0.25M	0.23M	0.22M	0.55M
Operating Expenses (Quarter)	0.67M	0.71M	0.87M	0.52M	0.55M	0.54M	0.53M	0.51M	0.49M	0.48M	0.46M	1.19M	0.45M	1.49M	0.42M	0.72M	0.58M	0.64M	1.43M	0.72M
Operating Income (Quarter)	-0.67M	-0.71M	-0.87M	-0.52M	-0.55M	-0.54M	-0.53M	-0.51M	-0.49M	-0.48M	-0.46M	-1.19M	-0.45M	-1.49M	-0.42M	-0.72M	-0.58M	-0.64M	-1.43M	1.89M
EBIT (Quarter)	-0.67M	-0.71M	-0.87M	-0.52M	-0.55M	-0.54M	-0.53M	-0.51M	-0.49M	-0.48M	-0.46M	-1.19M	-0.45M	-1.49M	-0.42M	-0.72M	-0.58M	-0.64M	-1.43M	1.89M
Non-operating items
Interest & Investment Income (Quarter)											0.05M	0.03M	0.03M	0.02M	0.01M	0.01M	0.00M	0.00M	0.00M	0.01M
Other Non Operating Income (Quarter)	0.09M									0.02M				0.02M
Non Operating Income (Quarter)	-0.28M	-2.05M	-2.31M	-0.65M	-0.50M	-0.50M	-0.29M	-0.43M	-0.08M	-0.11M	-0.09M	-0.14M	-0.06M	-0.12M	-0.01M	-0.14M	-0.02M	-0.09M	-0.08M	-0.06M
Net income details
EBT (Quarter)	-0.94M	-2.75M	-3.19M	-1.16M	-1.05M	-1.04M	-0.81M	-0.95M	-0.57M	-0.59M	-0.55M	-1.32M	-0.51M	-1.61M	-0.43M	-0.85M	-0.60M	-0.73M	-1.51M	-0.79M
Profit After Tax (Quarter)	-0.94M	-2.75M	-3.19M	-1.16M	-1.05M	-1.04M	-0.81M	-0.95M	-0.57M	-0.59M	-0.55M	-1.32M	-0.51M	-1.61M	-0.43M	-0.85M	-0.60M	-1.51M	-1.51M	-0.79M
Income from Continuing Operations (Quarter)	-0.94M	-2.75M	-3.19M	-1.16M	-1.05M	-1.04M	-0.81M	-0.95M	-0.57M	-0.59M	-0.55M	-1.32M	-0.51M	-1.61M	-0.43M	-0.85M	-0.60M	-0.73M	-1.51M	-0.79M
Consolidated Net Income (Quarter)	-0.94M	-2.75M	-3.19M	-1.16M	-1.05M	-1.04M	-0.81M	-0.95M	-0.57M	-0.59M	-0.55M	-1.32M	-0.51M	-1.61M	-0.43M	-0.85M	-0.60M	-0.73M	-1.51M	-0.79M
Income towards Parent Company (Quarter)	-0.94M	-2.75M	-3.19M	-1.16M	-1.05M	-1.04M	-0.81M	-0.95M	-0.57M	-0.59M	-0.55M	-1.32M	-0.51M	-1.61M	-0.43M	-0.85M	-0.60M	-0.73M	-1.51M	-0.79M
Net Income towards Common Stockholders (Quarter)	-0.94M	-2.75M	-3.19M	-1.16M	-1.05M	-1.04M	-0.81M	-0.95M	-0.57M	-0.59M	-0.55M	-1.32M	-0.51M	-1.61M	-0.43M	-0.85M	-0.60M	-0.73M	-1.51M	-0.79M
Additional items
EPS (Basic) (Quarter)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EPS (Weighted Average and Diluted) (Quarter)						0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Shares Outstanding (Weighted Average) (Quarter)	855.14M	858.56M	865.64M	877.61M	939.45M	949.45M	976.59M	974.31M	1,032.08M	1,032.73M	1,033.37M	1,033.12M	1,038.37M	1,038.37M	1,038.37M	1,038.37M	1,041.46M	1,047.49M	1,068.26M	1,059.49M
Shares Outstanding (Diluted Average) (Quarter)						955.15M	976.59M	974.31M	1,032.08M	1,032.73M	1,032.95M	1,033.12M	1,038.37M	1,038.37M	1,038.37M	1,038.37M	1,041.46M	1,044.49M	1,052.50M	1,059.49M
EBITDA (Quarter)	-0.67M	-0.71M	-0.87M	-0.52M	-0.55M	-1.04M	-0.81M	-0.95M	-0.57M	-0.58M	-0.56M	-1.32M	-0.51M	-1.61M	-0.43M	-0.72M	-0.58M	-0.64M	-1.43M	1.89M
Interest Expenses (Quarter)	0.13M	0.20M	0.19M	0.14M	0.16M	0.30M	0.07M	0.07M	0.12M	0.12M	0.12M	0.13M	0.13M	0.13M	0.13M	0.14M	0.14M	0.14M	0.14M	0.14M

Research Tools

Developers

Kraig Biocraft Laboratories Income Statement (2010-2025) | KBLB

Research Tools

Developers

Kraig Biocraft Laboratories Income Statement (2010-2025) | KBLB

Create an account

Sign In

Reset Password